You are here

  • Home
  • Archive
  • Volume 9, Issue 2
  • Short-term response to immune-chemotherapy and immune features of a ceritinib-resistant patient with ROS1-rearranged lung adenocarcinoma

Article metrics

Article menu

Download PDFPDF

XML
Case report
Short-term response to immune-chemotherapy and immune features of a ceritinib-resistant patient with ROS1-rearranged lung adenocarcinoma

 

Online download statistics by month:

Online download statistics by month: February 2021 to September 2024

AbstractFullPdf
Feb 2021300297156
Mar 202118918964
Apr 202111911957
May 202114714741
Jun 202115515537
Jul 202113213232
Aug 202112011947
Sep 2021999961
Oct 202111912039
Nov 202110110138
Dec 2021939320
Jan 2022646522
Feb 2022585827
Mar 202210110932
Apr 2022848617
May 2022838727
Jun 2022747723
Jul 2022687122
Aug 2022777732
Sep 2022696958
Oct 2022858840
Nov 2022565829
Dec 202239398
Jan 2023484816
Feb 2023646517
Mar 2023767715
Apr 2023393919
May 202329299
Jun 2023414113
Jul 2023353516
Aug 2023363613
Sep 2023302911
Oct 2023606125
Nov 2023494820
Dec 2023454512
Jan 2024363719
Feb 2024272715
Mar 2024373735
Apr 2024505226
May 2024262820
Jun 2024555517
Jul 2024697030
Aug 20244647110
Sep 2024676827
Total339734291414